发明名称 BENZOFURAN AND BENZTHIOPHENE DERIVATIVES
摘要 The invention provides compounds of general formula (I) or a physiologically acceptable salt, solvate or metabolically labile ester thereof wherein Q represents an oxygen or sulphur atom; R<1> represents a hydrogen atom or a halogen atom or a group selected from C1-6alkyl, C2-6alkenyl, fluoroC1-6alkyl, -CHO, -CO2H, C1-6alkoxy, or -COR<2>; Ar represents the group (a); R<2> represents a group selected from C1-6alkyl, C2-6alkenyl, C1-6alkoxy or the group -NR<12>R<13>; R<3> represents a group selected from -CO2H, -NHSO2CF3 or a C-linked tetrazolyl group; R<4> and R<5>, which may be the same or different, each independently represent a hydrogen atom or a halogen atom or a C1-6alkyl group; Het represents the group (b); X represents N or CH; Y represents N or CR<7>; Z represents N or CR<7>; R<6> represents a hydrogen atom or a C1-6alkyl, C2-6alkenyl or a C1-6alkylthio group; R<7> represents a halogen atom or a group selected from cyano, nitro, C1-6alkyl, C2-6alkenyl, fluoroC1-6alkyl, -(CH2)mR<8>, -(CH2)nCOR<9>, or -(CH2)pNR<10>COR<11>; R<8> represents a hydroxy or C1-6alkoxy group; R<9> represents a hydrogen atom or a group selected from hydroxy, C1-6alkyl, C1-6alkoxy, phenyl, phenoxy or the group -NR<12>R<13>; R<10> represents a hydrogen atom or a C1-6alkyl group; R<11> represents a hydrogen atom or a group selected from C1-6alkyl, C1-6alkoxy, phenyl, phenoxy or the group -NR<12>R<13>; R<12> and R<13>, which may be the same or different, each independently represent a hydrogen atom or a C1-4alkyl group or -NR<12>R<13> forms a saturated heterocyclic ring which has 5 or 6 ring members and may optionally contain in the ring one oxygen atom; m represents an integer from 1 to 4; n represents zero or an integer from 1 to 4; and p represents an integer from 1 to 4; with the proviso that at least one of X, Y and Z is a nitrogen atom, and with the further proviso that when X is N at least one of Y and Z is N and when Y is N at least one of X and Z is N. The compounds may be used in the treatment or prophylaxis of hypertension and diseases associated with cognitive disorders.
申请公布号 WO9209600(A1) 申请公布日期 1992.06.11
申请号 WO1991GB02114 申请日期 1991.11.28
申请人 GLAXO GROUP LIMITED 发明人 ROSS, BARRY, CLIVE;SCOPES, DAVID, IAN, CARTER;CARDWELL, KEVIN, STUART;ELDRED, COLIN, DAVID;MIDDLEMISS, DAVID;JACK, TORQUIL, IAIN, MACLEAN
分类号 A61K31/40;A61K31/4025;A61K31/415;A61P9/00;A61P9/12;A61P13/02;A61P15/00;A61P25/00;A61P27/02;A61P43/00;C07D307/79;C07D307/82;C07D333/28;C07D405/06;C07D405/10;C07D405/14;C07D409/06 主分类号 A61K31/40
代理机构 代理人
主权项
地址